TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Investor Investigation Over Possible Securities Laws Violations

  • If you purchased shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

September 27, 2013 (Update) - On September 25, 2013, AMAG Pharmaceuticals, Inc. disclosed that on September 23, 2013, the Company received a notification from the U.S. Food and Drug Administration (the FDA) stating that, as part of its ongoing review of the Companys supplemental New Drug Application for its Feraheme Injection, the FDA has identified deficiencies that preclude discussi...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)